• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

BMC Pulm Med . Association between peripheral lymphocyte count and the mortality risk of COVID-19 inpatients

tetano

Editor, Senior Moderator
BMC Pulm Med


. 2021 Feb 11;21(1):55.
doi: 10.1186/s12890-021-01422-9.
Association between peripheral lymphocyte count and the mortality risk of COVID-19 inpatients


Saibin Wang[SUP] 1 [/SUP], Yijun Sheng[SUP] 2 [/SUP], Junwei Tu[SUP] 2 [/SUP], Lanlan Zhang[SUP] 3 [/SUP]



Affiliations
Free article

Abstract

Background: To explore the relationship between peripheral lymphocyte counts (PLCs) and the mortality risk of coronavirus disease 2019 (COVID-19), as well as the potential of PLC for predicting COVID-19 hospitalized patients death.
Methods: Baseline characteristics, laboratory tests, imaging examinations, and outcomes of 134 consecutive COVID-19 hospitalized patients were collected from a tertiary hospital in Wuhan city from January 25 to February 24, 2020. Multiple regression analysis was used to analyze the relationship between the PLC at admission and mortality risk in COVID-19 patients and to establish a model for predicting death in COVID-19 hospitalized patients based on PLC.
Results: After adjusting for potential confounding factors, we found a non-linear relationship and threshold saturation effect between PLC and mortality risk in COVID-19 patients (infection point of PLC: 0.95 ? 10[SUP]9[/SUP]/L). Multiple regression analysis showed that when PLCs of COVID-19 patients were lower than 0.95 ? 10[SUP]9[/SUP]/L, the patients had a significantly higher mortality risk as compared to COVID-19 patient with PLCs > 0.95 ? 10[SUP]9[/SUP]/L (OR 7.27; 95% CI 1.10-48.25). The predictive power of PLC for death in COVID-19 patients (presented as area under the curve) was 0.78. The decision curve analysis showed that PLC had clinical utility for the prediction of death in COVID-19 inpatients.
Conclusions: PLC had a non-linear relationship with mortality risk in COVID-19 inpatients. Reduced PLCs (< 0.95 ? 10[SUP]9[/SUP]/L) were associated with an increased mortality risk in COVID-19 inpatients. PLCs also had a potential predictive value for the death of COVID-19 inpatients.

Keywords: Coronavirus disease 2019; Lymphocyte count; Mortality; Non-linear relationship; Prediction.
 
Back
Top Bottom